Announced Sat, 29 Aug, 2026 · 20:12 IST
Acutaas FY26 Annual Report: Revenue up 33%, PAT up 122%
Revenue Growth 20pctPat Growth 25pctEbitda Margin ExpansionResults View source PDFExplain this filing
ACUTAAS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
-3.3%1-day move
₹3264.10
prior close
₹3281.60
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-0.0-0.6-0.7-0.8-3.3-3.6-1.7-3.2-2.2-0.6-1.7+0.2——
Up moveDown movePending
AI summary
Acutaas Chemicals (formerly Ami Organics) reported FY26 revenue of Rs 13,394 Mn, up 33% YoY. EBITDA doubled to Rs 4,804 Mn (up 107%), while PAT surged 122% to Rs 3,564 Mn. RoCE hit a record 39.3%. Company stays debt-light with debt-equity of 0.02x and net cash of Rs 1,983 Mn. Capex of Rs 1,950 Mn deployed mainly for battery chemicals and the South Korea JV Indichem Inc. 19th AGM on September 24, 2026.
Likely market impact
Record profitability, debt-light balance sheet, and disciplined capex point to strong shareholder value creation and growth momentum.